Company
MatriSys Bioscience
MatriSys Bioscience is leading the discovery and clinical development of a novel class of biopharmaceuticals to transform the treatment of chronic skin diseases.
Also known as MatriSys Bioscience, Inc.
- Status
- Operatingas of 2026-09-19
- Business model
- B2B
- Legal name
- MatriSys Bioscience, Inc.
Record updated 28 September 2026
About
MatriSys Bioscience is leading the discovery and clinical development of a novel class of biopharmaceuticals to transform the treatment of chronic skin diseases. Our groundbreaking technology platform identifies beneficial bacteria derived from healthy human skin to potentially treat the millions of children and adults suffering from difficult to treat chronic skin diseases. Our lead clinical program focuses on patients with Atopic Dermatitis, we are also rapidly advancing therapeutics for Acne, Netherton and other skin disorders.
Funding snapshot
- Total raised
- $8.4MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $8.4M2022-07-15
Funding rounds
- Round, 2022
- $8.4M2022-07-15, SEC form D sold, 49 investors